STANDARD OF CARE CMT1, CMT2 and CMT4 are caused by mutations in > 80 genes. Despite the genetic heterogeneity there are clinical similarities in most patients, even if the speed of progression may vary. Distal wasting, weakness and sensory loss that begin in the lower limbs and progress proximally in a length-dependent manner characterize most forms of CMT. Despite progress in identifying its causes there are still no published comprehensive standards of care (SOC) for CMT. We have a unique opportunity to develop them. During the initial cycle of our RDCRC, we have enrolled over 6500 patients into the protocols of the INC. We have performed preliminary studies on the usage of next generation sequencing (NGS), the benefits of aerobic exercise and the approaches to orthopedic surgery in patients with CMT. All three of these areas are important to patients with CMT and all three lack SOC. In the upcoming cycle we propose the following three Specific Aims:
Aim 1 : Develop genetic diagnostic guidelines for CMT based on NGS technology.
Aim 2 : Develop evidence-based guidelines for the use of aerobic exercise in CMT.
Aim 3 : Convene an international workshop to develop SOC for CMT and to identify areas of SOC that need further study to develop evidence based guidelines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54NS065712-10
Application #
9344693
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2017-09-01
Budget End
2018-08-31
Support Year
10
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Hu, Bo; McCollum, Megan; Ravi, Vignesh et al. (2018) Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination. Ann Neurol 83:756-770
Dankwa, Lois; Richardson, Jessica; Motley, William W et al. (2018) A mutation in the heptad repeat 2 domain of MFN2 in a large CMT2A family. J Peripher Nerv Syst 23:36-39
Bai, Yunhong; Wu, Xingyao; Brennan, Kathryn M et al. (2018) Myelin protein zero mutations and the unfolded protein response in Charcot Marie Tooth disease type 1B. Ann Clin Transl Neurol 5:445-455
Rebelo, Adriana P; Saade, Dimah; Pereira, Claudia V et al. (2018) SCO2 mutations cause early-onset axonal Charcot-Marie-Tooth disease associated with cellular copper deficiency. Brain 141:662-672
Abbott, Jamie A; Meyer-Schuman, Rebecca; Lupo, Vincenzo et al. (2018) Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy. Hum Mutat 39:415-432
Abrams, Alexander J; Fontanesi, Flavia; Tan, Natalie B L et al. (2018) Insights into the genotype-phenotype correlation and molecular function of SLC25A46. Hum Mutat 39:1995-2007
Sandelius, Åsa; Zetterberg, Henrik; Blennow, Kaj et al. (2018) Plasma neurofilament light chain concentration in the inherited peripheral neuropathies. Neurology 90:e518-e524
Lassuthova, Petra; Rebelo, Adriana P; Ravenscroft, Gianina et al. (2018) Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2. Am J Hum Genet 102:505-514
Panosyan, Francis B; Kirk, Callyn A; Marking, Devon et al. (2018) Carpal tunnel syndrome in inherited neuropathies: A retrospective survey. Muscle Nerve 57:388-394
Synofzik, Matthis; Helbig, Katherine L; Harmuth, Florian et al. (2018) De novo ITPR1 variants are a recurrent cause of early-onset ataxia, acting via loss of channel function. Eur J Hum Genet 26:1623-1634

Showing the most recent 10 out of 189 publications